- ►nih.gov [PDF] - Free from Publisher I Widengård, O Mäepea, A Alm - British Journal of Ophthalmology, 1998 - bjo.bmj.com RESULTS Latanoprost alone reduced IOP from 19.3 (SD 1.4) to 14.8 (0.9) mm Hg
(p<0.01). Addition of dipivefrin caused a further reduction to 12.4 (0.9) mm Hg
(p<0.01 compared with latanoprost alone). In the group where the treatment ... Cited by 22 - Related articles - BL Direct - All 8 versions
AH Rulo, EL Greve, PF Hoyng - Ophthalmology, 1997 - ncbi.nlm.nih.gov OBJECTIVE: To investigate the additive ocular hypotensive effect of latanoprost
on the intraocular pressure (IOP) reduction induced by a suboptimal dose of
acetazolamide, a carbonic anhydrase inhibitor. DESIGN: A short-term, ... Cited by 27 - Related articles - BL Direct - All 6 versions
J Hedner, N Svedmyr, H Lunde, A Mandahl - Survey of ophthalmology, 1997 - Elsevier The use of beta blockers for glaucoma treatment may cause serious
bronchoconstriction in patients with chronic obstructive pulmonary disease. The
synthetic prostaglandin (PG) F2 α -analogue latanoprost (13,14,dihydro-17- ... Cited by 23 - Related articles - BL Direct - All 8 versions
- ►nih.gov [PDF] C Linden, E Nuija, A Alm - British Journal of Ophthalmology, 1997 - bjo.bmj.com AIMS To evaluate whether long term treatment with the prostaglandin analogue
latanoprost has a deleterious effect on the blood-aqueous barrier (BAB) and to
determine the duration of the effect on intraocular pressure (IOP) after ... Cited by 38 - Related articles - BL Direct - All 8 versions
Y Hotehama, HK Mishima - Japanese journal of ophthalmology, 1993 - cat.inist.fr Clinical efficacy of PhXA 34 and PhXA 41, two novel prostaglandin F
2 α-isopropyl ester analogues for glaucoma treatment. ... Cited by 49 - Related articles - All 3 versions
[CITATION] the Latanoprost Study Group. Latanoprost—two years' experience of its use in the United …
HK Mishima, K Masuda, Y Kitazawa, I Azuma, … - Archives of Ophthalmology, 1996 - archopht.highwire.org Methods: A total of 184 patients with primary open\x=req-\ angle glaucoma or
ocular hypertension at 35 medical cen- ters participatedin this randomized
double-masked study. The patients were randomized to receive either 0.005% ... Cited by 122 - Related articles - BL Direct - All 4 versions
PFJ Hoyng, A Rulo, E Greve, P Watson, A Alm - Survey of ophthalmology, 1997 - Elsevier Latanoprost, a prostaglandin F 2α analogue prodrug, has been shown to be an
effective ocular hypotensive agent when used alone on ocular hypertensive or
open angle glaucoma patients. In various studies, the ocular hypotensive ... Cited by 42 - Related articles - BL Direct - All 8 versions
G Selén, J Stjernschantz, B Resul - Survey of ophthalmology, 1997 - Elsevier Latanoprost, a new ocular hypotensive prostaglandin F 2α , analogue prodrug,
was found to induce increased pigmentation of monkey irides in chronic toxicity
studies. This prompted us to investigate the effect of naturally occurring ... Cited by 64 - Related articles - BL Direct - All 8 versions
